234 related articles for article (PubMed ID: 23806336)
1. FANCD2 activates transcription of TAp63 and suppresses tumorigenesis.
Park E; Kim H; Kim JM; Primack B; Vidal-Cardenas S; Xu Y; Price BD; Mills AA; D'Andrea AD
Mol Cell; 2013 Jun; 50(6):908-18. PubMed ID: 23806336
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.
Kim JM; Parmar K; Huang M; Weinstock DM; Ruit CA; Kutok JL; D'Andrea AD
Dev Cell; 2009 Feb; 16(2):314-20. PubMed ID: 19217432
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.
Parmar K; Kim J; Sykes SM; Shimamura A; Stuckert P; Zhu K; Hamilton A; Deloach MK; Kutok JL; Akashi K; Gilliland DG; D'andrea A
Stem Cells; 2010 Jul; 28(7):1186-95. PubMed ID: 20506303
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
Nijman SM; Huang TT; Dirac AM; Brummelkamp TR; Kerkhoven RM; D'Andrea AD; Bernards R
Mol Cell; 2005 Feb; 17(3):331-9. PubMed ID: 15694335
[TBL] [Abstract][Full Text] [Related]
5. Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program.
Helbling-Leclerc A; Dessarps-Freichey F; Evrard C; Rosselli F
Sci Rep; 2019 Nov; 9(1):17024. PubMed ID: 31745226
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitination of FANCD2 is required for DNA crosslink repair.
Oestergaard VH; Langevin F; Kuiken HJ; Pace P; Niedzwiedz W; Simpson LJ; Ohzeki M; Takata M; Sale JE; Patel KJ
Mol Cell; 2007 Dec; 28(5):798-809. PubMed ID: 18082605
[TBL] [Abstract][Full Text] [Related]
7. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
8. TAp63 induces senescence and suppresses tumorigenesis in vivo.
Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
[TBL] [Abstract][Full Text] [Related]
9. DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response.
Liang F; Miller AS; Longerich S; Tang C; Maranon D; Williamson EA; Hromas R; Wiese C; Kupfer GM; Sung P
Nat Commun; 2019 Jun; 10(1):2849. PubMed ID: 31253762
[TBL] [Abstract][Full Text] [Related]
10. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
11. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
13. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
14. Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.
Koptyra M; Stoklosa T; Hoser G; Glodkowska-Mrowka E; Seferynska I; Klejman A; Blasiak J; Skorski T
Leukemia; 2011 Aug; 25(8):1259-67. PubMed ID: 21519342
[TBL] [Abstract][Full Text] [Related]
15. Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.
Jang SW; Jung JK; Kim JM
Cell Cycle; 2016 Sep; 15(17):2336-45. PubMed ID: 27398742
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
[TBL] [Abstract][Full Text] [Related]
17. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.
Cohn MA; Kowal P; Yang K; Haas W; Huang TT; Gygi SP; D'Andrea AD
Mol Cell; 2007 Dec; 28(5):786-97. PubMed ID: 18082604
[TBL] [Abstract][Full Text] [Related]
18. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
19. The identification of FANCD2 DNA binding domains reveals nuclear localization sequences.
Niraj J; Caron MC; Drapeau K; Bérubé S; Guitton-Sert L; Coulombe Y; Couturier AM; Masson JY
Nucleic Acids Res; 2017 Aug; 45(14):8341-8357. PubMed ID: 28666371
[TBL] [Abstract][Full Text] [Related]
20. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
Montes de Oca R; Andreassen PR; Margossian SP; Gregory RC; Taniguchi T; Wang X; Houghtaling S; Grompe M; D'Andrea AD
Blood; 2005 Feb; 105(3):1003-9. PubMed ID: 15454491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
